Stock Scorecard
Stock Summary for Pacira BioSciences Inc (PCRX) - $23.22 as of 7/4/2025 1:53:51 AM EST
Total Score
6 out of 30
Safety Score
35 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for PCRX
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for PCRX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for PCRX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for PCRX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for PCRX (35 out of 100)
| Stock Price Rating (Max of 10) | 7 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 6 |
| Book Value to Price (Max of 10) | 1 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 2 |
| Trading Volume (Max of 10) | 4 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for PCRX
Financial Details for PCRX
Company Overview |
|
|---|---|
| Ticker | PCRX |
| Company Name | Pacira BioSciences Inc |
| Country | USA |
| Description | Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare professionals and their patients in the United States. The company is headquartered in Parsippany, New Jersey. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | 8/5/2025 |
Stock Price History |
|
| Last Day Price | 23.22 |
| Price 4 Years Ago | 60.17 |
| Last Day Price Updated | 7/4/2025 1:53:51 AM EST |
| Last Day Volume | 202,316 |
| Average Daily Volume | 571,305 |
| 52-Week High | 27.64 |
| 52-Week Low | 11.16 |
| Last Price to 52 Week Low | 108.06% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 21.93 |
| Sector PE | 40.90 |
| 5-Year Average PE | 18.20 |
| Free Cash Flow Ratio | 3.79 |
| Industry Free Cash Flow Ratio | 17.71 |
| Sector Free Cash Flow Ratio | 32.91 |
| Current Ratio Most Recent Quarter | 2.41 |
| Total Cash Per Share | 6.12 |
| Book Value Per Share Most Recent Quarter | 17.25 |
| Price to Book Ratio | 1.35 |
| Industry Price to Book Ratio | 34.53 |
| Sector Price to Book Ratio | 30.76 |
| Price to Sales Ratio Twelve Trailing Months | 1.53 |
| Industry Price to Sales Ratio Twelve Trailing Months | 121.97 |
| Sector Price to Sales Ratio Twelve Trailing Months | 35.60 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 46,304,700 |
| Market Capitalization | 1,075,195,134 |
| Institutional Ownership | 111.09% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -47.80% |
| Annual Earnings Growth | -337.30% |
| Reported EPS 12 Trailing Months | -2.24 |
| Reported EPS Past Year | 0.62 |
| Reported EPS Prior Year | 3.21 |
| Net Income Twelve Trailing Months | -103,727,000 |
| Net Income Past Year | -99,560,000 |
| Net Income Prior Year | 41,955,000 |
| Quarterly Revenue Growth YOY | 1.10% |
| 5-Year Revenue Growth | 10.73% |
| Operating Margin Twelve Trailing Months | 4.63% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 283,610,000 |
| Total Cash Past Year | 276,774,000 |
| Total Cash Prior Year | 153,298,000 |
| Net Cash Position Most Recent Quarter | -97,680,000 |
| Net Cash Position Past Year | -106,771,000 |
| Long Term Debt Past Year | 383,545,000 |
| Long Term Debt Prior Year | 513,796,000 |
| Total Debt Most Recent Quarter | 381,290,000 |
| Equity to Debt Ratio Past Year | 0.67 |
| Equity to Debt Ratio Most Recent Quarter | 0.68 |
| Total Stockholder Equity Past Year | 778,348,000 |
| Total Stockholder Equity Prior Year | 870,130,000 |
| Total Stockholder Equity Most Recent Quarter | 798,541,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 159,399,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 3.44 |
| Free Cash Flow Past Year | 178,753,000 |
| Free Cash Flow Prior Year | 139,488,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.37 |
| MACD Signal | -0.25 |
| 20-Day Bollinger Lower Band | 22.75 |
| 20-Day Bollinger Middle Band | 24.76 |
| 20-Day Bollinger Upper Band | 26.77 |
| Beta | 0.51 |
| RSI | 40.04 |
| 50-Day SMA | 20.65 |
| 150-Day SMA | 31.87 |
| 200-Day SMA | 39.19 |
System |
|
| Modified | 7/3/2025 7:40:02 AM EST |